AI designs drugs.
Our cells predict which ones will work.

AI designs drugs. Our cells predict which ones will work.

AI designs drugs. Our cells predict which ones will work.

Advanced organoids, diverse donors and Wet AI™

What Cytochroma Does

Cytochroma provides optimised cell models, high throughput screening and powerful data for superior drug discovery and validation.

We offer cardiac, hepatic and immune cells from diverse donors, allowing comprehensive, donor-matched model systems across diverse populations and diseases.

Cytochroma’s Wet AI™ platform generates rich, powerful phenotypic data and tackles the complexity of human biology in drug discovery.

Key Highlights

01

Optimised Cell Models

Cytochroma offers a range of iPSC-derived cell types from genetically diverse male and female donors, optimised for screening or combine to form multicellular models of health and disease.

01

Optimised Cell Models

Cytochroma offers a range of iPSC-derived cell types from genetically diverse male and female donors, optimised for screening or combine to form multicellular models of health and disease.

01

Optimised Cell Models

Cytochroma offers a range of iPSC-derived cell types from genetically diverse male and female donors, optimised for screening or combine to form multicellular models of health and disease.

02

Every Cell Type, Every Donor

Discover the widest library of commercially available hepatic and cardiac iPS derived cell types, representing a global population and aligning with FDA recommendations to improve inclusivity in drug development.

02

Every Cell Type, Every Donor

Discover the widest library of commercially available hepatic and cardiac iPS derived cell types, representing a global population and aligning with FDA recommendations to improve inclusivity in drug development.

02

Every Cell Type, Every Donor

Discover the widest library of commercially available hepatic and cardiac iPS derived cell types, representing a global population and aligning with FDA recommendations to improve inclusivity in drug development.

03

Cytochroma Wet AI™

Through large-scale wet-lab experiments and machine learning Cytochroma is building data sets that harnesses the complexity and diversity of human biology, driving faster more advanced drug discovery.

03

Cytochroma Wet AI™

Through large-scale wet-lab experiments and machine learning Cytochroma is building data sets that harnesses the complexity and diversity of human biology, driving faster more advanced drug discovery.

03

Cytochroma Wet AI™

Through large-scale wet-lab experiments and machine learning Cytochroma is building data sets that harnesses the complexity and diversity of human biology, driving faster more advanced drug discovery.

Prevent clinical failure before trials begin

Wet AI™ 
large-scale wet-lab screening

Human data as diverse as human biology.

We build ancestrally and genetically diverse human cell models, then screen your lead compounds against them. Find the winners, and the failures, before the clinic does.

We generate diverse data

Most preclinical data comes from a handful of near-identical cell lines. That is why compounds that pass preclinical still fail in real, diverse patients.

We manufacture HLA-typed, iPSC-derived human cells, hepatocytes, cardiomyocytes, Kupffer, stellate, endothelial and more, across ancestries and genotypes. Your data starts to look like the people your drug will actually treat.

We screen your lead compounds

Send us your leads. We run them across our diverse human cell panels and return efficacy, toxicity and phenotypic readouts you can act on.

See how a compound behaves across real human variation, not a single average, before you commit millions to the next phase.

Powered by Wet AI™

Every screen feeds our Wet AI™ platform, closing the loop between live human experiments and machine learning. Faster discovery, better targets, fewer expensive surprises downstream.

Got a lead compound you want de-risked?

Let's talk.

Partner with Cytochroma to advance your drug discovery journey.

scientist using a pipette with test tubes in a laboratory
scientist using a pipette with test tubes in a laboratory
scientist using a pipette with test tubes in a laboratory
orange and white medication pill
orange and white medication pill

New Approach Methologoies

A leader in New Approach Methodologies (NAMs). Cytochroma provides human iPSC-derived cell models, a next-generation NAM that replaces animal testing with biology that actually reflects people, offering one of the most genetically diverse panels available: donor-matched male and female cells across a range of ethnic backgrounds.

Built for the NAM regulatory shift. As the FDA Modernization Act and global regulators move drug development away from animal models toward human-relevant NAMs, our multi-donor panels bring population-level diversity into the earliest preclinical stages, generating more predictive, translatable data and reducing the risk of late-stage clinical failure.

NAMs at the speed and scale discovery now demands. Our high-throughput screening platform and banked, ready-to-use cells let pharma and biotech teams assess drug response and toxicity variability across diverse humans upfront, the validation layer that AI-driven discovery and modern NAM-based pipelines increasingly rely on.n making.  

diversity in preclinical testing

The FDA recommend testing in multiple donors.

At Cytochroma you can buy them all in one place in any cell type you need - If we don't stock it, we may be able to make it for you.

Donor-matched male and female cells across multiple ethnic backgrounds, delivers more predictive, translatable data.

Discover drug response and toxicity variability faster, reducing timelines and increase clinical success.

Cytochroma is pioneer in quality & diversity.

The FDA recommend testing in multiple donors.

At Cytochroma you can buy them all in one place in any cell type you need - If we don’t stock it, we may be able to make it for you.

Donor-matched male and female cells across multiple ethnic backgrounds, delivers more predictive, translatable data.

Discover drug response and toxicity variability faster, reducing timelines and increase clinical success.

Cytochroma is pioneer in quality & diversity.

orange and white medication pill
orange and white medication pill

Leaders in Science, Pioneers in diversity

Cytochroma supplies superior cell models and services to the pharmaceutical industry. Established in 2017, serving a global market, built on 5 core values:

Science:  pushing the boundary of knowledge

Innovation: think differently to build smarter systems that scale.

Quality: build human models for results you can trust every time.

Equality: represent equality and diversity, build inclusive teams

Sustainability: reduce remove and replace slow outdated systems.

Cytochroma is an Edinburgh-based biotechnology company that develops genetically diverse, human iPSC-derived cell models for drug discovery and safety testing. As a New Approach Methodology (NAM), Cytochroma provides donor-matched panels spanning male and female donors across multiple ethnic backgrounds, giving pharmaceutical and biotechnology teams human-relevant biology that reflects real patient populations rather than a single genetic average. Through high-throughput screening, Cytochroma generates the experimental validation data that AI-driven drug discovery increasingly depends on, confirming computational predictions of toxicity, drug response and target engagement in real, diverse human cells. By combining population-scale diversity with wet-lab throughput, Cytochroma helps researchers cut the risk of late-stage clinical failure and meet growing regulatory demand, including under the FDA Modernization Act, for evidence of safety and efficacy across diverse human populations.

Cytochroma is an Edinburgh-based biotechnology company that develops genetically diverse, human iPSC-derived cell models for drug discovery and safety testing. As a New Approach Methodology (NAM), Cytochroma provides donor-matched panels spanning male and female donors across multiple ethnic backgrounds, giving pharmaceutical and biotechnology teams human-relevant biology that reflects real patient populations rather than a single genetic average. Through high-throughput screening, Cytochroma generates the experimental validation data that AI-driven drug discovery increasingly depends on, confirming computational predictions of toxicity, drug response and target engagement in real, diverse human cells. By combining population-scale diversity with wet-lab throughput, Cytochroma helps researchers cut the risk of late-stage clinical failure and meet growing regulatory demand, including under the FDA Modernization Act, for evidence of safety and efficacy across diverse human populations.

Get in touch

For any inquiries or to explore your vision further, we invite you to contact our team using the details provided below.

Location

Cytochroma Limited, Roslin Innovation Centre, Charnock Bradley Building, Easter Bush Campus, Edinburgh, EH25 9RG, United Kingdom

Email

info@cytochroma.org

Phone

+44(0) 131 6519 715